Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cashflow Statement

INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹-75 Cr₹124 Cr₹193 Cr₹237 Cr₹132 Cr
Adjustment ₹184 Cr₹138 Cr₹121 Cr₹87 Cr₹110 Cr
Changes In working Capital ₹2.78 Cr₹-88 Cr₹-73 Cr₹-109 Cr₹-140 Cr
Cash Flow after changes in Working Capital ₹111 Cr₹173 Cr₹240 Cr₹215 Cr₹102 Cr
Cash Flow from Operating Activities ₹95 Cr₹155 Cr₹179 Cr₹174 Cr₹82 Cr
Cash Flow from Investing Activities ₹-339 Cr₹-433 Cr₹-208 Cr₹-121 Cr₹-67 Cr
Cash Flow from Financing Activities ₹241 Cr₹280 Cr₹23 Cr₹-44 Cr₹-30 Cr
Net Cash Inflow / Outflow ₹-2.76 Cr₹3.31 Cr₹-6.54 Cr₹8.05 Cr₹-14 Cr
Opening Cash & Cash Equivalents ₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr₹24 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -₹0.62 Cr---
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹12 Cr₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr

Compare Cashflow Statement of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,286.7 Cr 0.7% 7.2% -25.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹473,509.0 Cr 0.6% 6% 14.6% Stock Analytics
DIVIS LABORATORIES ₹196,881.0 Cr 1.2% 10.5% 7.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,832.0 Cr -0.4% 11% 40.8% Stock Analytics
CIPLA ₹113,894.0 Cr -1.6% -2.1% -4.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,062.8 Cr -4.6% -14.8% -8.4% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

0.7%

7.2%

-25.2%

SENSEX

-1.1%

-0.2%

-6.6%


You may also like the below Video Courses